Health Reform Roundtable Members Hold Conflicting Views On Device Tax Repeal For ACA Reform
Executive Summary
A group of high-level health policy analysts – including former Medicare and Medicaid officials and experts at policy groups including Families USA and the American Enterprise Institute – have crafted a bipartisan recommendation for Affordable Care Act reform, but are divided on if the 2.3% device excise tax created by ACA should be repealed.
You may also be interested in...
US House 'Problem Solvers,' AdvaMed, Aim To Repeal Device Tax
Two recent efforts to repeal the medical device tax include proposed legislation by a bipartisan "Problem Solvers" group of House members that includes a device-tax repeal provision, as well as an advertising campaign by AdvaMed.
'It's Time': AdvaMed Device Tax Ad Campaign Sets Sights On Key Lawmakers
While lawmakers are back in their districts during Congress' recess, AdvaMed is running local ads aimed at major congressional leaders to ensure they continue to prioritize repealing the 2.3% medical device excise tax.
Senate To Consider User Fee Bill Soon, As Hopes For BCRA Passage With Device Tax Repeal Fade
Sen. Lamar Alexander, R-Tenn., has placed the user fee FDA Reauthorization Act on the Senate legislative calendar, and is just waiting on a nod from the chamber leadership to bring it up for consideration on the floor. On July 18, after successfully passing an Agriculture/FDA funding bill for 2018 onto the full committee, Ag/FDA Subcommittee Chair John Hoeven, R-N.D., characterized FDARA as non-controversial and ripe for passage. Meanwhile, industries' hopes for device tax repeal as part of legislation repealing the Affordable Care Act are fading away.